clinical 1,451 words KG: LX1001 Long-Term Follow-up (NCT05400330) - Gene Therapy for APOE4 Homozygote AD
Contents

LX1001 Long-Term Follow-up (NCT05400330) - Gene Therapy for APOE4 Homozygote AD

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

Wikipedia

Related Hypotheses (42)

APOE Isoform Expression Across Glial Subtypes
Score: 0.74
Cholesterol-CRISPR Convergence Therapy for Neurodegeneration
Score: 0.62
Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.38
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.79
Competitive APOE4 Domain Stabilization Peptides
Score: 0.78
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.76
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.76
APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.74
Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.72
APOE Isoform Conversion Therapy
Score: 0.72
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.72
Gamma entrainment therapy to restore hippocampal-cortical sy
Score: 0.95
Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.78
CYP46A1 Overexpression Gene Therapy
Score: 0.77
SASP-Mediated Cholinergic Synapse Disruption
Score: 0.76
Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.76
Near-infrared light therapy stimulates COX4-dependent mitoch
Score: 0.74
PARP1 Inhibition Therapy
Score: 0.74
Sleep Spindle-Synaptic Plasticity Enhancement
Score: 0.72
Circadian Glymphatic Rescue Therapy (Melatonin-focused)
Score: 0.71
pg 1/3Next →

Related Analyses (19)

SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived

Related Experiments (10)

Sex Differences in Alzheimer's Disease — mechanisms and ther
clinical · proposed · Score: 0.40
AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi
clinical · proposed · Score: 0.40
AD Combination Therapy Trial: Anti-Aβ + Anti-Tau
clinical · proposed · Score: 0.40
ApoE4 Function in Alzheimer's Disease
validation · proposed · Score: 0.40
Biomarker-Guided Sequential Therapy Selection in Alzheimer's
clinical · proposed · Score: 0.40

See Also (15)

Neurodegeneration
disease · Pages share 10 hypotheses
ALA-enriched Nutrition for APOE4 Carriers with MCI (NCT
clinical · Pages share 10 hypotheses
APOE - Apolipoprotein E
scidex_docs · Pages share 10 hypotheses
LX1001 Phase 1/2 Trial (NCT03634007) - Gene Therapy for
clinical · Pages share 11 hypotheses
APOE contributes to Alzheimer's disease by regulating b
hypothesis · Pages share 10 hypotheses

Knowledge Graph (1 edges)

LX1001 Long-Term Follow-up (NCT05400330) - Gene Therapy for APOE4 Homozygote AD references APOE

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.